Major Histocompatibility Complex (MHC) / HLA: Exam Notes
Definition
Major histocompatibility complex (MHC) is a group of genes that encode cell-surface glycoproteins which bind peptide antigens and present them to T lymphocytes.
- In humans, MHC molecules are called Human Leukocyte Antigens (HLA).
- They were first identified on leukocytes but are present on many other cells.
- They act as an individual-specific genetic identity marker.
- They are important in:
- Antigen presentation to T cells
- Transplant rejection or graft acceptance
- Disease susceptibility
MHC presents peptide antigens, not intact antigens, to T cells. Class I mainly presents cytosolic antigens to CD8 T cells, while Class II mainly presents vesicular/exogenous antigens to CD4 T cells, as summarized in
NCBI Immunobiology.
Location and Organization of HLA Genes
- Located on the short arm of chromosome 6 (6p).
- HLA complex spans about 4000 kb.
- Contains more than 100 genes.
- Divided into three regions:
| MHC region | Important gene products / examples | Main role |
|---|
| Class I | HLA-A, HLA-B, HLA-C | Presents endogenous antigen to CD8 T cells |
| Class II | HLA-DP, HLA-DQ, HLA-DR | Presents exogenous antigen to CD4 T cells |
| Class III | Complement proteins, TNF, HSP70 | Inflammation and immune functions, not antigen presentation |
Key point
All three MHC regions are on chromosome 6, but only Class I and II directly participate in antigen presentation.
MHC Class I
Genes
These genes encode the alpha (α) chain of MHC Class I.
Distribution
Present on:
- All nucleated cells
- Platelets
Absent on:
- RBCs because they lack a nucleus
Structure
MHC Class I molecule consists of:
-
One α-chain
- Glycoprotein, approximately 45 kDa
- Encoded by HLA-A, HLA-B, or HLA-C
- Has three extracellular domains: α1, α2, α3
- Has a transmembrane segment and cytoplasmic tail
-
β2-microglobulin
- Approximately 12 kDa
- Non-glycosylated
- Encoded on chromosome 15, not chromosome 6
- Necessary for stable surface expression of MHC I
Peptide-binding groove
- Formed by the cleft between α1 and α2 domains.
- Binds peptides of 8-10 amino acids.
T-cell interaction
- α3 domain binds CD8 co-receptor.
- Therefore, MHC I presents antigen to CD8+ cytotoxic T cells.
Antigen source and pathway
- Presents endogenous / intracellular antigens.
- Examples:
- Viral proteins
- Tumor antigens
- Other cytosolic proteins
- Antigen processing occurs through the cytosolic pathway.
One-line answer
MHC Class I presents endogenous peptides of 8-10 amino acids to CD8+ cytotoxic T cells.
MHC Class II
Genes
Each has genes that encode both α and β chains.
Distribution
MHC Class II is expressed mainly on professional antigen-presenting cells (APCs):
- Dendritic cells
- Macrophages
- B lymphocytes
Structure
MHC Class II molecule consists of:
-
α-chain
- About 33 kDa
- Domains: α1 and α2
-
β-chain
- About 28 kDa
- Domains: β1 and β2
Both chains have transmembrane portions and cytoplasmic tails.
Peptide-binding groove
- Formed by the cleft between α1 and β1 domains.
- Binds peptides of 13-18 amino acids.
T-cell interaction
- β2 domain binds CD4 co-receptor.
- Thus, MHC II presents antigen to CD4+ helper T cells.
Antigen source and pathway
- Presents exogenous antigens that are taken up by endocytosis or phagocytosis.
- Examples:
- Extracellular bacteria
- Toxins
- Soluble proteins
- Antigen processing occurs through the endocytic pathway.
One-line answer
MHC Class II presents exogenous peptides of 13-18 amino acids to CD4+ helper T cells.
MHC Class III
Location and contents
- Lies between MHC Class I and MHC Class II regions.
- About 1000 kb long.
- Does not take part in antigen presentation.
It encodes:
- Complement components: C2, C4
- Factor B
- Properdin-related factors
- Heat shock protein 70 (HSP70)
- Tumor necrosis factor: TNF-α and TNF-β
- Steroid 21-hydroxylase
Exam point
MHC Class III genes code for inflammatory and complement-related proteins, not MHC antigen-presenting molecules.
Differences Between MHC Class I and MHC Class II
| Feature | MHC Class I | MHC Class II |
|---|
| Genes | HLA-A, HLA-B, HLA-C | HLA-DP, HLA-DQ, HLA-DR |
| Cells expressing it | All nucleated cells and platelets | APCs: dendritic cells, macrophages, B cells |
| Antigen origin | Endogenous / intracellular | Exogenous / extracellular |
| Examples of antigens | Viral and tumor antigens | Bacterial and soluble protein antigens |
| Processing pathway | Cytosolic pathway | Endocytic pathway |
| Peptide-binding groove | α1 + α2 | α1 + β1 |
| Peptide length | 8-10 amino acids | 13-18 amino acids |
| Presented to | CD8+ T cells | CD4+ T cells |
| Co-receptor binding domain | α3 binds CD8 | β2 binds CD4 |
| Molecular structure | α chain + β2-microglobulin | α chain + β chain |
| Main function | Cytotoxic T-cell response | Helper T-cell activation |
Mnemonic
“1 x 8 = CD8”
- MHC I presents 8-10 aa peptides to CD8 T cells.
“2 x 4 = CD4”
- MHC II presents to CD4 T cells.
Another memory aid:
- Class I = Inside antigen
- Class II = Ingested antigen
MHC in Transplantation
After graft transplantation:
- The recipient can mount an immune response against donor MHC molecules.
- Greater donor-recipient MHC mismatch leads to a greater likelihood of rejection.
- Better HLA matching improves graft compatibility.
Therefore, MHC molecules are termed histocompatibility antigens.
High-yield statement
HLA matching is important in organ and bone marrow transplantation because HLA disparity promotes graft rejection.
HLA and Disease Susceptibility
Certain HLA alleles are associated with increased susceptibility to diseases.
| HLA allele | Important association |
|---|
| HLA-B27 | Ankylosing spondylitis, reactive arthritis, Reiter syndrome |
| HLA-DR2 | Multiple sclerosis, Goodpasture syndrome |
| HLA-DR3 | Myasthenia gravis, systemic lupus erythematosus |
| HLA-DR3 / DR4 | Type 1 diabetes mellitus |
| HLA-DR4 | Rheumatoid arthritis |
| HLA-A3 / B14 | Hereditary hemochromatosis |
Must remember
- B27 = Ankylosing spondylitis
- DR4 = Rheumatoid arthritis
- DR3 = SLE
- DR3/DR4 = Type 1 diabetes mellitus
- DR2 = Multiple sclerosis
Association does not mean that the disease is inevitable. It indicates increased relative risk.
Very Short Notes for Revision
- MHC in humans = HLA system.
- Located on chromosome 6 short arm.
- MHC is polygenic and highly polymorphic.
- Class I: A, B, C, all nucleated cells, endogenous antigen, CD8, 8-10 aa peptide.
- Class II: DP, DQ, DR, APCs, exogenous antigen, CD4, 13-18 aa peptide.
- Class III: complement proteins, TNF, HSP70, no antigen presentation.
- MHC determines tissue compatibility and influences transplant rejection.
- β2-microglobulin is part of MHC I and is encoded on chromosome 15.
- Class I peptide groove = α1 + α2.
- Class II peptide groove = α1 + β1.
Common Exam Questions
- Define MHC. State its functions.
- Describe the genetic organization of human MHC.
- Compare MHC Class I and Class II molecules.
- Draw and label the structure of MHC Class I and Class II.
- Explain endogenous and exogenous antigen presentation pathways.
- Enumerate diseases associated with HLA alleles.
- Why is HLA matching important in transplantation?